At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 47 enrolled
Drug / intervention
Furosemide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure
In Brief
A Phase 3 clinical trial evaluating Furosemide and Torsemide for Heart Failure. Completed, enrolled 47 participants across 1 site.
Detailed Summary
The study is designed to be a prospective, randomized study is to compare the effectiveness of two standard of care loop diuretics (furosemide versus torsemide) on clinical outcomes among patients currently on a stable dose of loop diuretics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
202120222023202420252026
Enrollment StartFeb 2021
First PostedOct 2021
Primary CompletionJun 2023
TodayJul 2026
First PostedOct 26, 2021
Enrollment StartFeb 8, 2021
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.7 years ago
Interventions
Furosemidedrug
Standard of care diuretic
Torsemidedrug
Standard of care diuretic